Showing results (191-200 of 266) with videos related to
Sort By:
Pageof 27
Cancer Immunology Research|July 1, 2021
Activating Mucosal-Associated Invariant T Cells Induces a Broad Antitumor ResponseBenjamin Ruf, Vanessa V Catania, Simon Wabitsch, et al.Mucosal Immunology|June 23, 2021
Functional inactivation of pulmonary MAIT cells following 5-OP-RU treatment of non-human primatesShunsuke Sakai, Nickiana E Lora, Keith D Kauffman, et al.Nature Medicine|December 8, 2017
Corrigendum: Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cureStephanus T Malherbe, Shubhada Shenai, Katharina Ronacher, et al.Structure (London, England : 1993)|January 17, 2012
Structure of Ddn, the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis involved in bioreductive activation of PA-824Susan E Cellitti, Jennifer Shaffer, David H Jones, et al.Journal of Clinical Microbiology|April 27, 2012
Rapid, high-throughput detection of rifampin resistance and heteroresistance in Mycobacterium tuberculosis by use of sloppy molecular beacon melting temperature codingSoumitesh Chakravorty, Harsheel Kothari, Bola Aladegbami, et al.Plos One|October 3, 2013
Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosisThomas R Ioerger, Theresa O'Malley, Reiling Liao, et al.Journal of Medicinal Chemistry|July 16, 2011
Structure-activity relationships of antitubercular nitroimidazoles. 3. Exploration of the linker and lipophilic tail of ((s)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-amino PA-824)Joseph Cherian, Inhee Choi, Amit Nayyar, et al.Science Translational Medicine|December 5, 2014
PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosisM Teresa Coleman, Ray Y Chen, Myungsun Lee, et al.ACS Infectious Diseases|January 6, 2021
Structure-Activity Relationships of Pyrazolo[1,5-a]pyrimidin-7(4H)-ones as Antitubercular AgentsSangmi Oh, M Daben J Libardo, Shaik Azeeza, et al.Journal of Medicinal Chemistry|October 24, 2018
Discovery and Structure-Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β-d-ribose 2'-OxidaseSangmi Oh, Yumi Park, Curtis A Engelhart, et al.Pageof 27